Skip to main content
Loading

Increasing diversity in clinical trials to reduce health inequalities

15 Jun 2023
In conversation with...
In conversation with... , Supporter session

Integrated care systems (ICSs) have an ambition and statutory duty to improve population health outcomes and tackle inequalities. Also, under the Health & Care Act, ICSs are required to promote, facilitate and report on research.

These two duties are interdependent, given the critical role clinical research plays in addressing the unmet needs of patients and underserved communities through the development of new medicines and vaccines in clinical trials.

This session will examine the role of partnership working between industry and ICSs, in encouraging greater diversity in clinical trial participation, exploring challenges, barriers, opportunities and best practice examples.

This session is supported by the Association of the British Pharmaceutical Industry.

This session is part of the 'In Conversation With' Theatre, which is supported by the Association of the British Pharmaceutical Industry.

Speakers
Victoria Macdonald, Health and Social Care Editor - Channel 4 News
Andrew Clarke, Global Medical Lead - ViiV Healthcare
Imogen Shillito, Director of Stakeholder Engagement and Communications, CRN - NIHR
John James
Lindsey Hughes
ABPI